Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2025.08.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background And Aims: The role of anti-Müllerian hormone (AMH), a potential marker of the hypothalamic-pituitary-ovarian axis, is not well established in adolescent females. Typical epidemiologic studies use secondary sexual characteristics or chronological age as predictors for AMH. Skeletal maturity, an indicator of bone development, however, has not been examined in association with AMH in adolescent females.
View Article and Find Full Text PDFOvarian reserve markers in women of reproductive ages with epilepsy.
Epilepsy Behav
September 2025
The Epilepsy Clinic, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Objective: The objective of this study was to examine ovarian reserve parameters in women with epilepsy compared to women without epilepsy.
Methods: A total of 80 women with epilepsy (WWE) from the epilepsy clinic at Rigshospitalet, Denmark, participated and completed the study between 2018-2022. A historical cohort collected from 2008 to 2010 of 418 women without epilepsy and no prior diagnosis of infertility was used as control.
Study Question: Can patient age and ovarian reserve tests predict the number of cryopreserved oocytes in patients undergoing one or more ovarian stimulation cycles for elective oocyte cryopreservation (EOC)?
Summary Answer: A predictive model incorporating patient age, antral follicle count (AFC), anti-Müllerian hormone (AMH), and FSH levels achieved the greatest predictive accuracy.
What Is Known Already: As a consequence of societal evolution, women are increasingly delaying starting a family. However, the natural decline in ovarian reserve and oocyte quality as age advances can increase the risk of age-related fertility decline (ARFD) and involuntary childlessness.
Similar Outcomes, Different Timings: Luteal versus Follicular Stimulation in IVF.
Fertil Steril
September 2025
ART Fertility Clinic, Royal Marina Village, B22-23, Abu Dhabi, UAE.
Objective: To compare the impact of luteal-phase ovarian stimulation on embryo count, embryo ploidy, and embryo quality to that of follicular-phase stimulation.
Design: Retrospective cohort study between 03/2017 and 11/2024.
Subjects: Women who underwent an ovarian stimulation, commenced either in the follicular or the luteal phase of the menstrual cycle.
Age, AMH, and Oocyte Yield: Progress in prediction for elective oocyte cryopreservation.
Fertil Steril
September 2025
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Women and Infants Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: